| - GRCh37:
- Chr16:70303596
- GRCh38:
- Chr16:70269693
| AARS1 | R296Q | Developmental and epileptic encephalopathy, 29 | Uncertain significance (Apr 24, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr16:70310915
- GRCh38:
- Chr16:70277012
| AARS1 | T96I | Developmental and epileptic encephalopathy, 29 | Uncertain significance (Apr 24, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr16:70310970
- GRCh38:
- Chr16:70277067
| AARS1 | A78S | Developmental and epileptic encephalopathy, 29 | Uncertain significance (Jul 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:70316526
- GRCh38:
- Chr16:70282623
| AARS1 | N47K | Developmental and epileptic encephalopathy, 29 | Uncertain significance (Jun 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:70310961
- GRCh38:
- Chr16:70277058
| AARS1 | K81E | Developmental and epileptic encephalopathy, 29 | Uncertain significance (May 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:70311041
- GRCh38:
- Chr16:70277138
| AARS1 | L54P | Developmental and epileptic encephalopathy, 29 | Uncertain significance (May 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:70292997
- GRCh38:
- Chr16:70259094
| AARS1 | | Charcot-Marie-Tooth disease type 2 | Likely benign (Oct 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr16:70292978
- GRCh38:
- Chr16:70259075
| AARS1 | R633fs | Developmental and epileptic encephalopathy, 29 | Likely pathogenic | no assertion criteria provided |
| - GRCh37:
- Chr16:70316581
- GRCh38:
- Chr16:70282678
| AARS1 | S29F | Developmental and epileptic encephalopathy, 29 | Uncertain significance | no assertion criteria provided |
| - GRCh37:
- Chr16:70292045-70292046
- GRCh38:
- Chr16:70258142-70258143
| AARS1 | Y690fs | Developmental and epileptic encephalopathy, 29 | Pathogenic (Mar 2, 2022) | no assertion criteria provided |
| - GRCh37:
- Chr16:70293089
- GRCh38:
- Chr16:70259186
| AARS1 | P596S | Developmental and epileptic encephalopathy, 29 | Uncertain significance (Feb 3, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:70296346
- GRCh38:
- Chr16:70262443
| AARS1 | C525Y | Developmental and epileptic encephalopathy, 29 | Likely pathogenic (Jun 5, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:70305792-70305793
- GRCh38:
- Chr16:70271889-70271890
| AARS1 | S188L | Developmental and epileptic encephalopathy, 29 | Pathogenic (Jun 5, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:70310906
- GRCh38:
- Chr16:70277003
| AARS1 | E99G | Developmental and epileptic encephalopathy, 29 | Pathogenic | criteria provided, single submitter |
| - GRCh37:
- Chr16:70292906
- GRCh38:
- Chr16:70259003
| AARS1 | N657D | Charcot-Marie-Tooth disease type 2, Trichothiodystrophy 8, nonphotosensitive, Charcot-Marie-Tooth disease axonal type 2N, Developmental and epileptic encephalopathy, 29, Leukoencephalopathy, hereditary diffuse, with spheroids 2 | Uncertain significance (Sep 6, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70294991
- GRCh38:
- Chr16:70261088
| AARS1 | G581S | Developmental and epileptic encephalopathy, 29, Charcot-Marie-Tooth disease type 2 | Conflicting interpretations of pathogenicity (Dec 17, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:70316593
- GRCh38:
- Chr16:70282690
| AARS1 | Y25C | Developmental and epileptic encephalopathy, 29, Charcot-Marie-Tooth disease type 2, not provided
| Uncertain significance (Mar 17, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70292116
- GRCh38:
- Chr16:70258213
| AARS1 | V666A | not provided, Developmental and epileptic encephalopathy, 29, Charcot-Marie-Tooth disease type 2
| Conflicting interpretations of pathogenicity (Aug 23, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:70302257
- GRCh38:
- Chr16:70268354
| AARS1 | R330* | Developmental and epileptic encephalopathy, 29, Charcot-Marie-Tooth disease type 2 | Conflicting interpretations of pathogenicity (Jun 10, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:70304137
- GRCh38:
- Chr16:70270234
| AARS1 | T260A | Charcot-Marie-Tooth disease type 2, Developmental and epileptic encephalopathy, 29 | Conflicting interpretations of pathogenicity (Aug 13, 2021) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:70286658
- GRCh38:
- Chr16:70252755
| AARS1 | F958S | Developmental and epileptic encephalopathy, 29 | Likely pathogenic (Apr 25, 2018) | no assertion criteria provided |
| - GRCh37:
- Chr16:70303524
- GRCh38:
- Chr16:70269621
| AARS1 | R320H | Charcot-Marie-Tooth disease axonal type 2N, Leukoencephalopathy, hereditary diffuse, with spheroids 2, Trichothiodystrophy 8, nonphotosensitive, Developmental and epileptic encephalopathy, 29, Charcot-Marie-Tooth disease type 2, Inborn genetic diseases
| Uncertain significance (Jun 18, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70310943
- GRCh38:
- Chr16:70277040
| AARS1 | D87N | not provided, Charcot-Marie-Tooth disease type 2 | Uncertain significance (Aug 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70316697-70316698
- GRCh38:
- Chr16:70282794-70282795
| AARS1 | | not specified, Charcot-Marie-Tooth disease axonal type 2N, Developmental and epileptic encephalopathy, 29, Trichothiodystrophy 8, nonphotosensitive, Leukoencephalopathy, hereditary diffuse, with spheroids 2 | Likely benign (Oct 26, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70287177
- GRCh38:
- Chr16:70253274
| AARS1 | | Charcot-Marie-Tooth disease type 2, Developmental and epileptic encephalopathy, 29, not provided, Charcot-Marie-Tooth disease axonal type 2N | Benign (Nov 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70302201
- GRCh38:
- Chr16:70268298
| AARS1 | | Inborn genetic diseases, not provided, Charcot-Marie-Tooth disease axonal type 2N, Charcot-Marie-Tooth disease type 2, not specified, Charcot-Marie-Tooth disease axonal type 2N, Leukoencephalopathy, hereditary diffuse, with spheroids 2, Trichothiodystrophy 8, nonphotosensitive, Developmental and epileptic encephalopathy, 29
| Benign/Likely benign (Nov 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70286793
- GRCh38:
- Chr16:70252890
| AARS1 | G913D | Charcot-Marie-Tooth disease type 2, Developmental and epileptic encephalopathy, 29, not provided
| Conflicting interpretations of pathogenicity (Oct 28, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:70289731
- GRCh38:
- Chr16:70255828
| AARS1 | R729Q | Inborn genetic diseases, Charcot-Marie-Tooth disease type 2, Developmental and epileptic encephalopathy, 29, Charcot-Marie-Tooth disease axonal type 2N, not provided | Conflicting interpretations of pathogenicity (Oct 26, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:70298949
- GRCh38:
- Chr16:70265046
| AARS1 | | not specified, not provided, Inborn genetic diseases, Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease axonal type 2N, Charcot-Marie-Tooth disease axonal type 2N, Leukoencephalopathy, hereditary diffuse, with spheroids 2, Trichothiodystrophy 8, nonphotosensitive, Developmental and epileptic encephalopathy, 29
| Benign/Likely benign (Nov 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70286631
- GRCh38:
- Chr16:70252728
| AARS1 | K967M | Charcot-Marie-Tooth disease axonal type 2N, Charcot-Marie-Tooth disease type 2, not provided, Charcot-Marie-Tooth disease axonal type 2N, Leukoencephalopathy, hereditary diffuse, with spheroids 2, Developmental and epileptic encephalopathy, 29, Trichothiodystrophy 8, nonphotosensitive | Benign/Likely benign (Oct 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70304215
- GRCh38:
- Chr16:70270312
| AARS1 | P234S | Inborn genetic diseases, Charcot-Marie-Tooth disease type 2, Leukoencephalopathy, hereditary diffuse, with spheroids 2, Trichothiodystrophy 8, nonphotosensitive, Charcot-Marie-Tooth disease axonal type 2N, Developmental and epileptic encephalopathy, 29, not provided, Charcot-Marie-Tooth disease axonal type 2N | Benign/Likely benign (Sep 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70295064
- GRCh38:
- Chr16:70261161
| AARS1 | | Inborn genetic diseases, not specified, Charcot-Marie-Tooth disease type 2, not provided, Leukoencephalopathy, hereditary diffuse, with spheroids 2, Trichothiodystrophy 8, nonphotosensitive, Charcot-Marie-Tooth disease axonal type 2N, Developmental and epileptic encephalopathy, 29, Charcot-Marie-Tooth disease axonal type 2N
| Benign/Likely benign (Oct 1, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:70289666
- GRCh38:
- Chr16:70255763
| AARS1 | R751G | Inborn genetic diseases, Charcot-Marie-Tooth disease, not provided, AARS-related disorders, Charcot-Marie-Tooth disease type 2 | Conflicting interpretations of pathogenicity (Nov 3, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr16:70310960
- GRCh38:
- Chr16:70277057
| AARS1 | K81T | not provided | Likely pathogenic (Jun 3, 2015) | criteria provided, single submitter |